She is currently a member and project team leader on major pharmaceutical consortia efforts to advance the science of preclinical safety testing, including the Predictive Safety Testing Consortium Hepatic Working Group, the Health and Environmental Sciences Institute’s (HESI) Application of Genomics to Mechanism-Based Risk Assessment Technical Committee, and the HESI Committee on Biomarkers of Nephrotoxicity. Dr. Harrill received her Ph.D. in Toxicology from the University of North Carolina at Chapel Hill. Dr. Harrill has received several awards for her translational research that include the Outstanding Published Paper in Advancing the Science of Risk Assessment Award (2009) and Top 10 Abstract Award (2013) from the Risk Assessment Specialty Section of the Society of Toxicology.